http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103063794-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9555e093690931ba0e980bdddc4e802
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-89
filingDate 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085bdf4ef24d0324bdc732decc374e1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d274f203de86013df8dfc1439501b917
publicationDate 2014-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103063794-B
titleOfInvention Content detecting and control method of epalrestat tablets
abstract The invention discloses a content detecting and control method of epalrestat tablets, according to the method, high-performance liquid chromatography is used for detecting the epalrestat tablets. Analytical conditions such as an optimal internal standard compound, mobile phase composition, an elution program, elution flow velocity, a detecting wavelength and a chromatographic column are optimized through a large number of experiments. Many times of experimental verification indicates that the content detecting and control method of the epalrestat tablets is good in stability and repeatability, high in analysis efficiency, good in resolution and capable of detecting epalrestat sensitively and accurately in a qualitative and quantitative mode, so that the quality of the epalrestat tablets can be evaluated objectively, comprehensively and accurately, and the content detecting and control method of the epalrestat tablets is of great significance in controlling of the quality of the epalrestat tablets and ensuring of clinical effects.
priorityDate 2012-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004110488-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203

Total number of triples: 25.